Detalhe da pesquisa
1.
Non surgical predicting factors for patient satisfaction after third molar surgery.
Med Oral Patol Oral Cir Bucal
; 21(2): e201-5, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26827054
2.
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study.
BMC Cancer
; 15: 327, 2015 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25925749
3.
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study.
Cancers (Basel)
; 14(19)2022 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230628
4.
Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study.
Sci Rep
; 10(1): 7741, 2020 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32385335
5.
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP).
Breast
; 54: 286-292, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33242755
6.
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study.
Cancer Chemother Pharmacol
; 53(1): 75-81, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14557896
7.
Cost-benefit analysis of a follow-up program in patients with breast cancer: a randomized prospective study.
Breast J
; 13(6): 571-4, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17983398